In this study, we tested simultaneous stimulation of death receptor-mediated apoptosis and inhibition of EGFR downstream signaling via MSC-mediated release of the bi-functional molecule EVDRL as a new strategy for the treatment of NSCLC and LM resulting from NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.